Table 1.
Relationship between CD146 expression and clinicopathological features in patients with ccRCC.
| Variable | No. of patients (%) | χ2 | p-value | ||
|---|---|---|---|---|---|
| Patients | CD146 high | CD146 low | |||
| Age (years) | |||||
| ≤60 | 104 | 50(48.1) | 54(51.9) | 1.126 | 0.289 |
| > 60 | 36 | 21(58.3) | 15(41.7) | ||
| Gender | |||||
| Male | 108 | 53(49.1) | 55(50.9) | 0.509 | 0.476 |
| Female | 32 | 18(56.3) | 14(43.8) | ||
| T stage | |||||
| T1+T2 | 106 | 49(46.2) | 57(53.8) | 3.517 | 0.061 |
| T3+T4 | 34 | 22(64.7) | 12(35.3) | ||
| N stage | |||||
| N0 | 128 | 64(50.0) | 64(50.0) | 0.305 | 0.581 |
| N1 | 12 | 7(58.3) | 5(41.7) | ||
| M stage | |||||
| M0 | 134 | 66(49.3) | 68(50.7) | 2.668 | 0.102 |
| M1 | 6 | 5(83.3) | 1(16.7) | ||
| Fuhrman grade | |||||
| Grade 1 + 2 | 100 | 39(59.6) | 61(40.4) | 19.215 | 0.000 |
| Grade 3 + 4 | 40 | 32(83.7) | 8(16.3) | ||